Radon Indication Registry - a multi-centre, hypothesis-generating, explorative, uncontrolled,non-interventional, open registry study for the assessment of pain reduction, increase of quality of life and improvement in functionality throughout low-dose radon hyperthermia therapy

Gastein Research Institute0 个研究点目标入组 5,000 人开始时间: 2021年10月11日最近更新: 2023年8月21日

试验速览

2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35922780/ Results from ankylosing spondylitis patients (added 11/10/2022) 2023 Interim results article in https://pubmed.ncbi.nlm.nih.gov/37361027/ Pain symptons in patients with rheumatic musculoskeletal diseases (added 01/08/2023)

•1. Age >25, <75 years
•2. No radon therapy within the last year
•3. BMI >18, <34 kg/m²
•4. Being diagnosed one of the six possible indications (ankylosing spondylitis, rheumatoid arthritis, back pain, osteoarthritis in hip and knee, fibromyalgia syndrome, psoriasis arthritis)
•5. Being able to attend any form of radon therapy performed in the Gastein Valley

•1. Severe cardiovascular disease/arrhythmia
•2. Severe kidney dysfunction/inflammatory kidney participation in the context of an autoimmune disease
•3. Acute infections
•4. Highly acute attack in chronic polyarthritis
•5. Hyperthyroidism
•6. Malignancy patients: last accomplished chemotherapy or immune therapy has taken place <1 year ago
•7. Pregnancy
•8. Alcohol and/or drug abuse
•9. Lacking language skills
•10. Incapability of filling out a questionnaire

发起方

Gastein Research Institute